U.S. flag

An official website of the United States government

NM_000430.4(PAFAH1B1):c.162dup (p.Trp55fs) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 3, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000364082.7

Allele description [Variation Report for NM_000430.4(PAFAH1B1):c.162dup (p.Trp55fs)]

NM_000430.4(PAFAH1B1):c.162dup (p.Trp55fs)

Gene:
PAFAH1B1:platelet activating factor acetylhydrolase 1b regulatory subunit 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
17p13.3
Genomic location:
Preferred name:
NM_000430.4(PAFAH1B1):c.162dup (p.Trp55fs)
HGVS:
  • NC_000017.11:g.2666060dup
  • NG_009799.1:g.77432dup
  • NM_000430.4:c.162dupMANE SELECT
  • NP_000421.1:p.Trp55fs
  • NC_000017.10:g.2569346_2569347insA
  • NC_000017.10:g.2569354dup
  • NC_000017.11:g.2666052_2666053insA
  • NM_000430.3:c.162dup
  • NM_000430.3:c.162dupA
  • p.Trp55Metfs*6
Protein change:
W55fs
Links:
dbSNP: rs113994198
NCBI 1000 Genomes Browser:
rs113994198
Molecular consequence:
  • NM_000430.4:c.162dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000329811GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Apr 10, 2018)
germlineclinical testing

Citation Link,

SCV003442376Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 3, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation.

Pilz DT, Matsumoto N, Minnerath S, Mills P, Gleeson JG, Allen KM, Walsh CA, Barkovich AJ, Dobyns WB, Ledbetter DH, Ross ME.

Hum Mol Genet. 1998 Dec;7(13):2029-37.

PubMed [citation]
PMID:
9817918

Clinical and molecular diagnosis of Miller-Dieker syndrome.

Dobyns WB, Curry CJ, Hoyme HE, Turlington L, Ledbetter DH.

Am J Hum Genet. 1991 Mar;48(3):584-94.

PubMed [citation]
PMID:
1671808
PMCID:
PMC1682996
See all PubMed Citations (5)

Details of each submission

From GeneDx, SCV000329811.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.162dupA pathogenic variant in the PAFAH1B1 gene has been reported previously as a de novo variant in an individual with isolated lissencephaly sequence (Pilz et al., 1998). The duplication causes a frameshift starting with codon Tryptophan 55, changes this amino acid to a Methionine residue and creates a premature Stop codon at position 6 of the new reading frame, denoted p.Trp55MetfsX6. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Additionally, it was not observed in approximately 6,300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003442376.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant is also known as LIS1 c.162insA. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 21181). This premature translational stop signal has been observed in individual(s) with lissencephaly (PMID: 9817918). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Trp55Metfs*6) in the PAFAH1B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAFAH1B1 are known to be pathogenic (PMID: 1671808, 11115846, 14581661).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024